Some good news for women who have started to grow “bored” with sex; who have female sexual dysfunction, and who want to increase their sex drive, is the approval of the Pink Viagra by the U.S. Food and Drug Administration.
The Pink Viagra, also called flibanserin or Addyi, has been finally approved for release on October 2015.
The drug reportedly increases the sex drive of sexually hypoactive women. The downside, however, is that it can only be given to women who are still not menopausal. For women, who are already on their menopausal stages, they should seek their doctor’s approval before availing of Addyi.
Addyi has side effects such as, dizziness, acute hypotension (sudden drop in blood pressure) and light-headedness. Addyi can also interact with other drugs and substances such as, alcohol, CYP3A4 inhibitors, some antibiotics, antifungals, blood pressure and HIV drugs. Hence, Addyi must only be taken after careful evaluation of the woman’s medical and personal history.
The safety of women, who want to use this pink Viagra, is ensured by the company through the release of the drug only by certified agencies and specialists.
